NewLimit Grabs $435M Funding
2026-06-09
Tweet
SOUTH SAN FRANCISCO, CA. NewLimit, a biotechnology company, has closed a $435M Series C funding led by Founders Fund.
NewLimit, a biotechnology companym has closed a $435M Series C led by Founders Fund alongside new investors Thrive Capital, Greenoaks, and Quiet Capital, and returning investors Kleiner Perkins, Abstract, Nat Friedman/Daniel Gross, Valor Equity Partners, Eli Lilly Ventures, Human Capital, and others.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors
